Anjali Sharma

Title: Anjali Sharma: Innovator in Dendrimer Delivery Systems

Introduction

Anjali Sharma is a prominent inventor based in Baltimore, MD (US). She has made significant contributions to the field of drug delivery systems, particularly through her innovative work on dendrimer formulations. Her research focuses on developing effective methods for delivering therapeutic agents to treat various diseases and conditions.

Latest Patents

Anjali Sharma holds a patent for a "Dendrimer delivery system and methods of use thereof." This patent describes low-generation dendrimers that contain a high density of surface hydroxyl groups. Specifically, it details oligo ethylene glycol (OEG)-like dendrimers with a high number of surface functional groups at relatively low generations, such as approximately 120 hydroxyls in the third generation, with a size of just 1-2 nm. The patent also outlines dendrimer formulations that include one or more prophylactic, therapeutic, and/or diagnostic agents. These formulations are suitable for topical, enteral, and/or parenteral delivery, particularly for treating diseases and conditions associated with the eye, brain, and nervous system, especially those linked to the pathological activation of microglia and astrocytes.

Career Highlights

Anjali Sharma is affiliated with The Johns Hopkins University, where she continues her research and development in innovative drug delivery systems. Her work has garnered attention for its potential to improve treatment outcomes for various medical conditions.

Collaborations

Anjali has collaborated with notable colleagues, including Kannan Rangaramanujam and Rishi Sharma, to advance her research in dendrimer technology and its applications in medicine.

Conclusion

Anjali Sharma's contributions to the field of dendrimer delivery systems highlight her innovative spirit and dedication to improving healthcare solutions. Her work exemplifies the impact of research and innovation in addressing complex medical challenges.